Loading institutional data...
Loading institutional data...
No institutional (13F) filings cover this company, so the Overview and 13F tabs are thin. Everything drawn from its SEC filings is here.
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Modest payoff on reinvested capital. Current ROIC on all capital: -1%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $34.0M covers the $7.5M due within a year 4.5× over. Scheduled principal only (excludes interest & revolver draws). As of 2017-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~6.1% on $1.88B of debt.
Cash of $167.9M is below short-term debt of $412.0M — relies on refinancing/operations.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
What the company returns to shareholders — and whether it's covered by cash.
Free-cash-flow coverage unavailable. Last year: $20.9M dividends + $0 buybacks = $20.9M returned.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
EOD close · as of 2026-10-21
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.80B 100.0% | $1.72B 100.0% | $1.66B 100.0% | $1.59B 100.0% | $1.87B 100.0% | $1.73B 100.0% | $1.95B 100.0% | $1.92B 100.0% | $1.64B 100.0% | $1.35B 100.0% |
| Cost of Revenue | $2.46B 64.9% | $1.09B 63.5% | $1.08B 64.8% | $1.06B 66.7% | — | — | — | $1.38B 72.0% | $961.1M 58.8% | $803.8M 59.5% |
| Cost of Products | — | — | — | — | — | — | — | — | $961.1M 58.8% | $803.8M 59.5% |
| Cost of Services | — | — | — | — | — | — | — | — | $203.3M 12.4% | $166.0M 12.3% |
| Gross Profit | — | — | — | $255.0M 16.0% | $219.6M 11.8% | $223.5M 12.9% | $263.6M 13.5% | $233.6M 12.2% | $189.8M 11.6% | $158.3M 11.7% |
| Research & Development | $116.3M 3.1% | $20.9M 1.2% | $20.5M 1.2% | $23.0M 1.4% | $22.0M 1.2% | $29.3M 1.7% | $28.5M 1.5% | $26.9M 1.4% | $28.7M 1.8% | $23.6M 1.7% |
| Selling, General & Admin | — | — | $409.6M 24.6% | $389.7M 24.5% | $351.4M 18.8% | $358.5M 20.7% | $396.4M 20.4% | $346.8M 18.1% | $325.2M 19.9% | $267.4M 19.8% |
| Total Operating Expenses | — | — | — | — | — | — | — | — | $57.6M 3.5% | $64.3M 4.8% |
| Operating Income | $189.4M 5.0% | $118.4M 6.9% | $164.7M 9.9% | $132.6M 8.3% | $125.6M 6.7% | $163.1M 9.4% | $188.2M 9.7% | $143.8M 7.5% | $143.8M 8.8% | $101.0M 7.5% |
| Interest Expense | $114.4M 3.0% | $19.4M 1.1% | $24.3M 1.5% | $16.3M 1.0% | -$11.2M -0.6% | $13.9M 0.8% | $18.8M 1.0% | $13.9M 0.7% | $13.6M 0.8% | $9.4M 0.7% |
| Interest & Investment Income | — | — | — | — | — | — | — | — | — | $1.6M 0.1% |
| Pretax Income | -$62.4M -1.6% | $95.3M 5.6% | $153.1M 9.2% | $120.0M 7.5% | $119.5M 6.4% | $145.5M 8.4% | $166.9M 8.6% | $129.0M 6.7% | $132.2M 8.1% | $94.0M 7.0% |
| Income Tax Expense | -$13.1M -0.3% | $10.7M 0.6% | $23.5M 1.4% | $16.2M 1.0% | $27.0M 1.4% | $36.7M 2.1% | $37.6M 1.9% | $24.6M 1.3% | $50.1M 3.1% | $26.0M 1.9% |
| Net Income | -$50.5M -1.3% | $85.4M 5.0% | $582.6M 35.0% | $137.4M 8.6% | $119.1M 6.4% | $108.8M 6.3% | $129.0M 6.6% | $104.1M 5.4% | $80.5M 4.9% | $67.6M 5.0% |
| Per Share | ||||||||||
| EPS (Basic) | -$0.98 | $2.67 | $18.21 | $4.29 | $3.72 | $3.40 | $4.04 | $3.26 | $2.56 | $2.30 |
| EPS (Diluted) | -$0.98 | $2.65 | $18.13 | $4.28 | $3.71 | $3.39 | $4.02 | $3.23 | $2.53 | $2.27 |
| Weighted Avg Shares (Basic) | 52.0M | 32.0M | 32.0M | 32.0M | 32.0M | 32.0M | 31.9M | 31.9M | 31.4M | 29.4M |
| Weighted Avg Shares (Diluted) | 52.0M | 32.2M | 32.1M | 32.1M | 32.1M | 32.1M | 32.0M | 32.2M | 31.9M | 29.8M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company doesn't have positive free cash flow on any basis, so a reverse DCF can't be run.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-10-21
Where each multiple sits in its own 16-yr range · 29th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 16-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE -1% against ROIC -1% — -0% of the return on equity comes from leverage and buybacks rather than from the operating business.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
Low operating leverage — profit tracks sales closely (stable, less cyclical).
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 72.0 | — | — | — | 66.7 | 64.8 | 63.5 | 64.9 |
| Gross Profit | 12.2 | 13.5 | 12.9 | 11.8 | 16.0 | — | — | — |
| R&D | 1.4 | 1.5 | 1.7 | 1.2 | 1.4 | 1.2 | 1.2 | 3.1 |
| SG&A | 18.1 | 20.4 | 20.7 | 18.8 | 24.5 | 24.6 | — | — |
| Operating Income | 7.5 | 9.7 | 9.4 | 6.7 | 8.3 | 9.9 | 6.9 | 5.0 |
| Income Tax | 1.3 | 1.9 | 2.1 | 1.4 | 1.0 | 1.4 | 0.6 | -0.3 |
| Net Income | 5.4 | 6.6 | 6.3 | 6.4 | 8.6 | 35.0 | 5.0 | -1.3 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on JBTM: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Cash conversion and accruals. The full answer — share-based compensation, the cash conversion waterfall, working-capital trend — is still being built, so this block states what it measures rather than issuing a verdict.
One year is not a trend. The spec asks for a 3- and 5-year average of FCF/net income precisely because a single year turns on working-capital timing, and that arrives with the full Q2 block.